Joshi Abhay 4
4 · Revance Therapeutics, Inc. · Filed Oct 2, 2020
Insider Transaction Report
Form 4
Joshi Abhay
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2020-09-30$25.14/sh−7,382$185,583→ 111,950 total - Award
Common Stock
2020-09-30+17,500→ 119,332 total
Footnotes (2)
- [F1]Represents shares of Common Stock received upon partial settlement of a performance share award (the "PSA") on September 30, 2020.
- [F2]Represents the number of shares withheld by and surrendered to the Issuer on September 30, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of the PSA.